Controversy Surrounds Palantir’s Role in NHS Data Management
“This is exactly the use case that you don’t outsource, and you certainly don’t outsource outside the country,” Laura Gilbert, senior director of AI at the Tony Blair Institute, a think tank founded by the former prime minister, told WIRED. “We should learn from this data and build a better health service, not allowing an offshore company to learn and create better products that they could sell to someone else.”
Amidst the ongoing debates regarding the UK’s National Health Service (NHS) collaboration with Palantir, a prominent data analytics company, concerns have been raised about the implications of such partnerships. Gilbert’s apprehension highlights a broader skepticism about outsourcing sensitive health data management, particularly to foreign entities.
Palantir’s Federated Data Platform: A Double-Edged Sword?
Ayub Bhayat, director of data and analytics at the NHS, told WIRED that the federated data platform helps patients “while saving money for NHS teams and taxpayers”.
Bhayat emphasizes the potential benefits of Palantir’s federated data platform, which aims to enhance patient care while optimizing financial resources. However, the lack of stringent usage requirements raises questions about data governance and control.
Concerns Over National Security and Values
In early June, MPs published a report warning that the UK’s growing reliance on Palantir represents “an unacceptable point of weakness”. The company is set to become heavily involved in the public sector, the parliamentary committee argued, which would give it immense leverage over the British state. The report also describes a “clear mismatch with British values”.
The UK Parliament’s report underscores the potential risks associated with Palantir’s deepening involvement in public sector data management. Highlighting a “clear mismatch with British values,” the report warns against over-reliance on a single entity, which could wield significant influence over national infrastructure.
Governmental Review and Public Backlash
After the report was published, UK Technology Secretary Liz Kendall said the government was carrying out a review of “every aspect” of the NHS contract with Palantir before deciding whether to pursue the deal.
In response to parliamentary concerns, the UK government has initiated a comprehensive review of the NHS’s contract with Palantir. This scrutiny reflects growing public unease regarding the potential misuse of sensitive health data.
Palantir’s Defense and Public Perception
Responding to the report in an editorial published by The Telegraph, Mosley accused MPs of “putting politics before patients” and sowing fear over the possibility that the company could abuse its access to sensitive health data. “Each NHS trust controls its own data; Palantir cannot use, sell or move it,” he wrote.
Palantir’s defense, articulated by Mosley, aims to assuage fears by emphasizing that NHS trusts retain control over their data. Despite these assurances, public skepticism persists, fueled by concerns over data privacy and control.
Legal Battles and Protests
Whether or not the government decides to pursue the NHS contract, Palantir has demonstrated its willingness to resist attempts to oust it from the UK public sector. According to the Times, the company is preparing to sue London Mayor Sadiq Khan, who blocked a $65 million deal with the Metropolitan Police, citing concerns about the procurement process and “values.”
Palantir’s potential legal action against London Mayor Sadiq Khan highlights its determination to remain entrenched within the UK public sector. This ongoing saga underscores the contentious nature of data management partnerships.
Public Sentiment and Patient Trust
Hours after the protests began, demonstrators retreated to a cafe at the nearby public library.
The group shared optimism about the growing momentum behind calls to expel Palantir from the NHS, particularly following the parliamentary report. “We have a really big opportunity right now, thanks to the break clause,” says Lurken, co-founder of Pull the Plug.
But there is also a world in which renewed public attention to the Palantir issue could backfire, some believe, if the government decides to move forward with the contract. Another protester, who gave his name as JJ and identified himself as an NHS practitioner, said he feared that Palantir’s notoriety could make already nervous patients think twice before voluntarily providing information to their healthcare provider, with implications for their care. “We know that people don’t want to tell us everything. People are already suspicious. They will just keep quiet,” explains JJ. “We’re going to get less information, less story to be able to help people.”
Amidst protests and public discourse, concerns about patient trust and data transparency loom large. The potential chilling effect on patient disclosure could hinder healthcare providers’ ability to offer comprehensive care.
For more information, visit the original article on WIRED: Here.
“`
